| Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283) |
|---|
| 02/24/2010 | EP1748995B1 Arylsulfonyl benzodioxanes useful for modulation the 5-ht6 receptor, the 5-ht2areceptor or both |
| 02/24/2010 | EP1458675B1 Alpha-cyanoacrylates |
| 02/23/2010 | US7667053 Cannabinoid-1 (CB1) receptor antagonists and/or inverse agonists; e.g. N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1,4-benzodioxane-2-carboxamide; psychological disorders, eating disorders |
| 02/18/2010 | WO2010019911A2 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions |
| 02/18/2010 | WO2010018209A1 Method of obtaining lactide |
| 02/18/2010 | WO2009084773A3 Preparation process useful in synthesis of atorvastatin |
| 02/18/2010 | US20100041902 Polylactones made from 3-cyclohexyl-1,4-dioxan-2,5-dione or dicyclohexylglycolide; high glass transition temperature and improved clarity; environmentally friendly renewable, biodegradable polymers; packaging, medical applications, fibers |
| 02/18/2010 | US20100041656 Novel amide derivatives and medicinal use thereof |
| 02/18/2010 | CA2734305A1 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions |
| 02/17/2010 | EP2152661A2 Coproduction of cyclic carbonates and of nitriles and/or of fatty amines |
| 02/17/2010 | EP1565430B1 Biguanide derivatives |
| 02/17/2010 | EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 02/17/2010 | CN101648938A Recrystallization purifying device for lactide |
| 02/16/2010 | US7662979 cyanation; dopamine autoreceptor agonists and partial agonists at postsynaptic dopamine D2 receptor; for treating dopaminergic disorders such as schizophrenia, schizoaffective disorder, Parkinson's disease, Tourette's syndrome, hyperprolactinemia, and drug addiction |
| 02/16/2010 | CA2452918C New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 02/11/2010 | US20100035872 Pde10 inhibitors and related compositions and methods |
| 02/11/2010 | US20100035865 Sulfonamides and Pharmaceutical Compositions Thereof |
| 02/10/2010 | EP2150550A1 Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |
| 02/10/2010 | EP2150111A1 Substituted 1,3-dioxanes useful as ppar modulators |
| 02/09/2010 | CA2315646C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 02/04/2010 | US20100029588 Substituted phenylamidines and the use thereof as fungicides |
| 02/03/2010 | CN100586942C Production method of dioxane |
| 02/03/2010 | CN100586921C Method for refining lactide |
| 02/02/2010 | US7655641 3-(4-{2-[(5-Fluoro-3- methyl-benzo[b]thiophene-2- sulfonyl)-propyl- amino]-ethylsulfanyl}- 2-methyl-phenyl)- propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, hypertension, arteriosclerosis and cardiovascular diseases |
| 01/28/2010 | WO2010011548A1 Novel substituted sulfamide derivatives |
| 01/28/2010 | CA2731295A1 Novel substituted sulfamide derivatives |
| 01/27/2010 | EP1532095B1 Method for producing aldehydes by means of hydroformylation of olefinically unsaturated compounds, said hydroformylation being catalysed by unmodified metal complexes in the presence of cyclic carbonic acid esters |
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/27/2010 | CN101633654A Ring carbonic ester monomer containing acrylate class functional group as well as preparation and application thereof |
| 01/26/2010 | US7652031 Compounds which mimic the chemical and biological properties of discodermolide |
| 01/26/2010 | US7652006 Substituted 1(2H)-phthalazinones and pharmaceutical compositions thereof |
| 01/26/2010 | CA2270581C Aryloxypropanolamine derivatives, method of preparation and applications thereof |
| 01/21/2010 | WO2010008776A2 Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems |
| 01/21/2010 | WO2009120192A3 Processes for the preparation of benzo-fused dioxin derivatives |
| 01/20/2010 | EP1758853B1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 01/20/2010 | EP1654247B1 Alkynyl aryl carboxamides |
| 01/20/2010 | CN101628909A Method for synthesizing 1,4-dioxane-2-ketone by ethylene glycol |
| 01/20/2010 | CN100582111C Process for the production of the spiroglycol |
| 01/19/2010 | US7649005 Substituted benzylaminoalkylene heterocycles |
| 01/14/2010 | WO2010003624A2 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| 01/14/2010 | WO2010003299A1 A flavor enhancer and preparation method thereof |
| 01/13/2010 | EP1713755B1 Method for producing 2,5-dimethylphenyl acetic acid |
| 01/13/2010 | CN101624390A Preparation method of key intermediate of rosuvastatin calcium side chain |
| 01/13/2010 | CN101624389A Flavoring agent and method for preparing same |
| 01/12/2010 | US7645891 E.g., 4-(2-methyl-3-oxo-hept-6-en-2-yl)-2,2-dimethyl-[1,3]-dioxane chemical intermediate; chemical/metabolic stabilization of microtubuli; antitumor, -carcinogenic agents; malignant melanoma, acute lymphocytic/myelocytic leukemia; angiogenesis inhibitors; antiinflammatory/-arthritic agents; psoriasis |
| 01/12/2010 | US7645761 Indoline derivatives |
| 01/07/2010 | WO2010000193A1 Preparation of osemozotan and its pharmaceutically acceptable salts, and its intermediate |
| 01/07/2010 | US20100004471 Purification of p-dioxanone |
| 01/07/2010 | US20100004470 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 01/07/2010 | US20100004222 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same |
| 01/06/2010 | EP2141157A1 Purification of p-dioxanone using isocyanate derivatives |
| 01/06/2010 | EP2139859A1 Dechalcogenative methods for the preparation of allylic sulfides |
| 01/05/2010 | US7642363 Chemical intermediates providing simple route for preparation of HMG CoA reductase inhibitors; crystalline, high purity; precursors for statins |
| 01/05/2010 | US7641914 Acid-sensitive compounds, their preparation and uses |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/03/2010 | CA2668908A1 Purification of p-dioxanone |
| 12/30/2009 | WO2009130422A3 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway |
| 12/30/2009 | EP2137178A2 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
| 12/30/2009 | CN101616907A Method for purification of cyclic ester |
| 12/30/2009 | CN101613341A Synthetic method of key intermediate of rosuvastatin calcium side chain |
| 12/30/2009 | CN100575334C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 12/24/2009 | US20090318544 Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
| 12/23/2009 | WO2009153886A1 PROCESS FOR PRODUCING α-HYDROXY ACID |
| 12/23/2009 | EP1796657B1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 12/23/2009 | CN101611085A Phosphorus-sulfur fr additives and polymer systems containing same |
| 12/23/2009 | CN100572426C Novel oxonol compound and process for producing the compound |
| 12/17/2009 | WO2009150966A1 Tetracyclic liquid crystalline compound having lateral fluorine, liquid crystal composition and liquid crystal display element |
| 12/17/2009 | WO2009150963A1 Pentacyclic liquid crystal compound having cyclohexane ring, liquid crystal composition and liquid crystal display element |
| 12/17/2009 | WO2009150248A1 Compounds which can be used for the treatment of cancers |
| 12/17/2009 | US20090312392 Amino ceramide-like compounds and therapeutic methods of use |
| 12/17/2009 | US20090312363 Bifunctional histone deacetylase inhibitors |
| 12/17/2009 | US20090311403 Method of Using Organic Compounds |
| 12/17/2009 | US20090309066 Mixture of polar compounds containing cyclohexane and benzene rings some of which are vinylene-linked, especially containing fluoroalkoxy groups; for electrooptical twisted nematic monitor applications |
| 12/17/2009 | CA2727296A1 Compounds which can be used for the treatment of cancers |
| 12/16/2009 | EP2133346A1 Method of manufacturing a cyclic diester of an alpha-hydroxylated acid |
| 12/10/2009 | US20090306333 Bifunctional lactide monomer derivative and polymers and materials prepared using the same |
| 12/10/2009 | US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 12/10/2009 | US20090302273 Five-ring liquid crystal compound having cyclohexane ring, liquid crystal composition, and liquid crystal display device |
| 12/09/2009 | EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 12/08/2009 | US7629476 chemical intermediates; 2-chloromethyl-5,5-dimethyl-2-(2,5-dimethylphenyl)-[1,3]dioxane |
| 12/08/2009 | CA2422342C Novel amide derivatives and medicinal use thereof |
| 12/03/2009 | US20090298949 Aminoalkylphenols, methods of using and making the same |
| 12/03/2009 | DE10124480B4 Pentafluorosulfuranylbenzol-Derivate und deren Verwendung Pentafluorosulfuranylbenzol derivatives and their use |
| 12/02/2009 | EP2128152A1 Method for cleaning cyclic diesters of L and D lactic acid |
| 12/02/2009 | EP2128151A1 Method for purification of cyclic ester |
| 12/02/2009 | EP2125946A2 Phosphorus-sulfur fr additives and polymer systems containing same |
| 12/02/2009 | EP2124558A2 Substituted 1,3-dioxanes and their uses |
| 12/02/2009 | EP2124551A2 Substituted 1,3-dioxanes and their uses |
| 12/02/2009 | CN101591327A Benzene alkyl amides compound and usage thereof |
| 12/01/2009 | CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 11/25/2009 | EP2120567A1 Prodrugs of substituted 1,3-dioxanes and their uses |
| 11/25/2009 | EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides |
| 11/25/2009 | CN101585828A Annular aliphatic carbonate monomer with three bond lateral group and preparation method |
| 11/25/2009 | CN101585827A Method for preparing lactide with high yield |
| 11/19/2009 | US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few |
| 11/18/2009 | EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators |
| 11/18/2009 | EP1358172B1 Amino ceramide-like compounds and therapeutic methods of use |
| 11/17/2009 | CA2450801C Drugs that enhance synaptic responses mediated by ampa receptors |
| 11/12/2009 | WO2008117305A3 A novel process for preparing pregabalin and its acid addition salts |
| 11/11/2009 | EP2116522A1 Pentacyclic liquid crystal compound having cf<sb>2</sb>o bonding group, liquid crystal composition and liquid crystal display |